Novartis Comprehensive Leprosy Care Association - Company Profile

It is a sports private not for profit company based in Bandra, Maharashtra, India, established in 1994.

1994 Bandra, Maharashtra, India Under Liquidation

Last Updated: July 20, 2025

About Novartis Comprehensive Leprosy Care Association

Novartis Comprehensive Leprosy Care Association, a under liquidation private not for profit company, was established on 31 March 1994 in Bandra, Maharashtra, India. Engaging in sports & events within the sports sector, it holds CIN: U92410MH1994NPL077457. Registered under ROC Roc Mumbai. it is unlisted.

It upholds a compliant status. Its leadership includes Shilpa Shashank Joshi (Director), Kumudini Dinesh Bhalerao (Irp/Rp/Liquidator), Sanjeev Shrivastav (Director). Past directors included Klaus Michael Leisinger, Monaz Noble, Nikhil Malpani. Its latest AGM occurred on 25 June 2024, with the balance sheet filed on 31 March 2024. It is based at Inspire Bkc 7Th Floor Bandra Kurla Complex, Bandra East, Bandra, Maharashtra, 400051.

Company Details

CIN/LLPIN
U92410MH1994NPL077457
Registration Number
077457
Incorporation Date
31 March 1994
Paid-Up Capital
₹8.00 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Under Liquidation

Key Metrics

Paid Up Capital ₹ 8.00 M as on 20-07-2025
Company Age 31 Year, 10 Months
Last Filing with ROC 31 Mar 2024
Revenue Growth **** -14.38% (FY 2024)
Profit Growth **** -163.82% (FY 2024)
Ebitda **** 100.00% (FY 2024)
Net Worth -100.00% (FY 2024)
Total Assets -36.12% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Novartis Comprehensive Leprosy Care Association — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Novartis Comprehensive Leprosy Care Association?

Current Directors

Name	Designation	Appointment Date	Status
Shilpa Shashank Joshi	Director	28 Oct 2022	Current
Kumudini Dinesh Bhalerao	Irp/Rp/Liquidator	06 Aug 2024	Current
Sanjeev Shrivastav	Director	17 Sep 2019	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	18 Jul 2013	Past
Pramod Abcsdd	Director	22 Nov 2022	Past
Pramod Abcsdd	Additional Director	29 Sep 2022	Past
Pramod Abcsdd	Additional Director	25 Sep 2023	Past
Pramod Abcsdd	Director	01 Dec 2021	Past
Pramod Abcsdd	Director	18 Sep 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novartis Comprehensive Leprosy Care Association.

Novartis Comprehensive Leprosy Care Association, for the financial year ended 2024, experienced significant reduction in revenue, with a 14.38% decrease. The company also saw a substantial fall in profitability, with a 163.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 100%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-14.38%

*******

Revenue from Operations

*******

Total Assets

*******

-36.12%

*******

Profit or Loss

*******

-163.82%

*******

Net Worth

*******

-100.00%

*******

EBITDA

*******

100.00%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novartis Comprehensive Leprosy Care Association?

Unlock access to Novartis Comprehensive Leprosy Care Association's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Novartis Comprehensive Leprosy Care Association?

Unlock and access historical data on people associated with Novartis Comprehensive Leprosy Care Association, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Novartis Comprehensive Leprosy Care Association, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novartis Comprehensive Leprosy Care Association's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novartis Comprehensive Leprosy Care Association

Recent Activity within the Organization

Director Appointment

Progress on Kumudini Dinesh Bhalerao was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 06 Aug 2024 & has been associated with this company since 1 year 6 months . was documented.
06 Aug 2024
Annual General Meeting

Progress on Novartis Comprehensive Leprosy Care Association last Annual general meeting of members was held on 25 Jun 2024 as per latest MCA records. was documented.
25 Jun 2024
Balance Sheet

Novartis Comprehensive Leprosy Care Association has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
31 Mar 2024
Director Appointment

The activity Shilpa Shashank Joshi was appointed as a Director was appointed as a Director on 28 Oct 2022 & has been associated with this company since 3 years 4 months . was completed.
28 Oct 2022
Director Appointment

Sanjeev Shrivastav was appointed as a Director was appointed as a Director on 17 Sep 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
17 Sep 2019
Company Incorporation

The activity Novartis Comprehensive Leprosy Care Association was registered on 31 Mar 1994 with Roc Mumbai & aged 31 years 10 months as per MCA records. was completed.
31 Mar 1994

Explore recent activity and updates - View Recent Activity